祥生医疗(688358)披露2025年限制性股票激励计划草案,10月13日股价下跌0.12%

Core Viewpoint - Wuxi Xiangsheng Medical Technology Co., Ltd. is set to hold its second extraordinary general meeting of shareholders on October 17, 2025, to discuss the 2025 Restricted Stock Incentive Plan, aimed at establishing a long-term incentive mechanism for employees [1] Group 1: Stock Performance - As of the close on October 13, 2025, Xiangsheng Medical's stock price was 33.8 yuan, down 0.12% from the previous trading day [1] - The stock opened at 32.03 yuan, reached a high of 33.84 yuan, and a low of 32.03 yuan during the trading session [1] - The total market capitalization of the company is 3.79 billion yuan, with a trading volume of 65.291 million yuan and a turnover rate of 1.75% [1] Group 2: Shareholder Meeting Agenda - The upcoming shareholder meeting will review the proposal for the 2025 Restricted Stock Incentive Plan and its summary [1] - The meeting will also discuss the management measures for the implementation of the incentive plan and seek authorization for the board of directors to handle specific matters related to the stock incentive plan [1] - The authorization will cover aspects such as determining the grant date, adjustments to quantity and price, and the granting and lifting of restrictions on rights [1]